Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials

Published:2022-06 Issue:3 Volume:7 Page:100485
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Ghanem I.,Lora D.,Herradón N.,de Velasco G.,Carretero-González A.,Jiménez-Varas M.Á.,Vázquez de Parga P.,Feliu J.

Funder

Baxter International

Pfizer

Bayer Fund

Astellas Pharma US

Roche España

Amgen

Servier

Bristol-Myers Squibb

Merck

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

3. More deaths from pancreatic cancer than breast cancer in the EU by 2017;Ferlay;Acta Oncol,2016

4. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017

5. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial;Conroy;Lancet Oncol,2021

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments;Frontiers in Oncology;2024-07-01

2. The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER database;Expert Review of Anticancer Therapy;2024-04-29

3. Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials;PLOS ONE;2024-03-07

4. The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis;Annals of Surgical Oncology;2024-02-22

5. The Survival Effect of Neoadjuvant Therapy and Neoadjuvant Plus Adjuvant Therapy on Different AJCC 8th TNM Stages: A Propensity Score Matching Analysis Based on SEER Database;2023-11-14